Oxidative damage induced by free globin chains has been implicated in the pathogenesis of the membrane abnormalities observed in a and B thalassemia. We have evaluated transport of Na+ and K+ in erythrocytes of patients with thalassemias as well as in two experimental models that use normal human red blood cells, one for a thalassemia (methylhydrazine treatment, a thalassemia like) and one for /3 thalacurmia (phenylhydrazine treatment, /3 thalassemia like). With the exception of the Na-K pump, similar alterations in membrane transport were observed in thalassemia and thalassemia-like erythrocytes. These were: increased KCl cotransport, Na-Li countertransport and reduced Na-K-Cl HEREAS MOLECULAR DEFECTS responsible for decreased globin chain synthesis in thalassemias have been described in great detail, the membrane damage imposed by the presence of free a or p chains is complex and less well characterized. Morphologic, biochemical, and metabolic changes of the erythrocyte membrane contribute to the premature destruction of thalassemic erythrocytes. Thus, membrane damage represents an important mechanism leading to anemia in thala~semias."~ Previous studies in thalassemic erythrocytes have shown several alterations in membrane lipids and an increase in globin binding to membrane skeleton' and a decrease in membrane thiol^.^" a and p thalassemias are characterized by different membrane skeleton protein abnormalities and different cell deformability features.6s7 Many of these alterations are suggestive of an increased cell oxidative damage?.'
an increase in globin binding to membrane skeleton' and a decrease in membrane thiol^.^" a and p thalassemias are characterized by different membrane skeleton protein abnormalities and different cell deformability features.6s7 Many of these alterations are suggestive of an increased cell oxidative damage?. ' One of the features that distinguishes severe p from a thalassemia is the presence of erythrocyte dehydration? p thalassemia minor red blood cells (RBCs) were shown to lose potassium (K+) after incubation in serumg or in autologous plasma," probably as a consequence of the activation of the Gardos pathway induced by adenosine triphosphate (ATP) depletion and increased Ca influx.'' Studies by Nathan et a l l z suggested a relationship between this abnormal K+ leak and hemoglobin (Hb) precipitation on the membrane. Studies in sickle cell anemia, where cellular dehydration is prominent, have shown a marked activation of the K-Cl ~0transport.l~"~ This system induces K+ loss and cell shrinkage when the cells are swollen or exposed to acid [(Dihydro-indenyl) oxy] Alkanoic acid (DIOA), a specific inhibitor for this systern,l6 is effective in reducing K+ loss induced by K-Cl cotransport both in normalI7 and in oxygenated17 or deoxygenated sickle cells." K-Cl cotransport is also found in reticulocyte-rich but not in mature fractions of normal human RBCs." The activation of K-Cl cotransport observed in S S and CC RBCs cannot be explained exclusively on the basis of an increased number of reticulocytes. Increased K-Cl cotransport has been reported in P-thalassemia RBCsZo and in erythrocytes containing positively Some of the features of the membrane damage observed in thalassemic RBCs can be reproduced by incorporating free a chains into normal RBCs, with the dialysis exchange hemolysis techniq~e.'~.~ An excess of denatured a or p Hb chains with associated iron, heme, or hemichromes' is responsible for the generation of free radicals leading to the oxidative damage of the cell membrane in thalassemic RBCs.'.' Schrier and Mohandas have shown that the membrane protein abnormalities observed in severe or a thalassemia can be reproduced in normal RBCs by exposure to the oxidants phenylhydrazine (PHZ) and methylhydrazine (MHZ), respectively (p-and a-thalassemia-like cells').
In this paper, we examined the principal RBC cation transport pathways in a-and &thalassemic RBCs. The effects on membrane transport of PHZ and MHZ treatment of normal human RBCs were also studied as well as those of DIOA and dithiothreitol (Dm) treatment. The maximal rates of Na-K pump and Na-K-Cl cotransport activity were measured in cells containing equal amounts of Na and K (50 mmol/L of cells, obtained with nystatin technique). With this procedure the internal sites for both transport system are ~aturated.'~ The nystatin-loadmg solution contained 70 mmom NaCI, 70 mmoU L KCI, and 55 mmoVL sucrose. Na-K pump was estimated as the oubain-sensitive fraction on Na+ efflux into a media containing 130 mmol/L choline chloride and 10 mmol/L KCI. Triplicate samples were incubated for 5 minutes and 25 minutes at 37°C. The ouabain concentration was 0.1 mrnol/L. Na-K-Cl cotransport was estimated as the bumetanide-sensitive fraction of the Na+ and K+ efflux into a media containing 140 mmoVL choline chloride and 0.1 mmol/L ouabain. The efflux times were 5 minutes and 25 minutes at 37°C with triplicate samples. The bumetanide concentration was 0.01 mmol/L. All media contained 1 mmol/L MgClz, IO mmol/L glucose, and 10 mmol/L TIUS-MOPS (pH 7.4 at 37°C).
MATERIALS AND METHODS

Drugs
K-Cl cotransport from fresh cells was measured as either chloridedependent or volume-dependent K+ efflux. Flux media for chloridedependent K efflux containing 100 mmoVL Na' and 1 mmo& MgZ* (the anion being either Cl-or NO;), 10 mmol/L glucose and 10 mmol/L TRIS-MOPS (pH 7.4 at 37°C). Chloride-dependent K' efflux was calculated as the difference between K' efflux in chloride and nitrate media. Swelling-induced K+ flux was calculated as the difference between K' efflux in NaCl hypotonic (IO0 mol/L) and in NaCl isotonic (140 mmol/L) media. Incubation times at 37°C for flux measurements were 5 and 25 minutes. DIOA was used at a final concentration of 0.1 mmol/L.
When D'IT was used, thalassemic and oxidant-treated cells were washed with CWS at 4°C and reincubated for additional 30 minutes at 37°C in isotonic-buffered KC1 (130 mmol/L) solution containing 10 mmolL D V . After four washes with CWS at 4°C cells were used for K+ efflux measurements, as described above.
Na-Li exchange was estimated as the external Na+-stimulated Li' efflux (differences between Li' efflux into 140 mmoVL NaCl and 140 mmol/L choline chloride) from cells containing 20 m o l Li+/ L cells. The nystatin procedure (loading solution with 110 mmol/L KCI, 30 mmom LiCl and 55 mmoVL sucrose) was used to modify the red cell cation composition.'' Na-H exchange was estimated as the Na' efflux stimulated by hypertonic shrinkage (500 mOsrn) from cells containing equal amounts of Na and K (nystatin technique). The media contained 140 mmoVL choline chloride and the osmolarity was increased with sucrose. 5-(N,N-hexamethylene-amiloride 10 pmoVL final concentration) was used as the specific inhibitor of the system. All media contained 1 mmol/L MgC12, 10 m o V L glucose, 10 mol/L TRIS-MOPS (pH 7.4 at 37"C), 0.1 m m o K ouabain and 10 pmol/L bumetanide.
Preparation of thalassemia-like cells. Human erythrocytes containing normal Hb were incubated at 10% hematocrit with different concentrations of PHZ and MHZ (from 0.5 to 10 mmol/L) in a medium containing 130 mmom KCI, 10 mmol/L NaCI, 1 mmol/L NaCI, 1 mmoI/L MgClz, 1 mmoVL K phosphate buffer, pH 7.4 and 10 mmol/L glucose (60 min at 37°C). At the end of the incubation, cells were washed five times in CWS and then processed as described above to measure cation transport. When experiments with DTT were performed, the oxidized cells were reincubated for additional 30 minutes at 37°C in isotonic buffered KC1 (130 mmol/L) solution containing 10 mmol/L DTT. After four washes with CWS at 4"C, cells were used for K' efflux measurement. In preliminary experiments, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis was performed after oxidative treatment and showed membrane protein abnormalities similar to those described by Schrier and Mohandas.'
Cell density separation. To obtain density-fractionated light cells (density < 1.096) and dense cells (density > 1 .l 14) discontinuous Percoll density gradient was used.z5 Density-separated cells were washed four times with CWS at 4°C and immediately used for cation transport measurements, as described above.
RESULTS
Cation transport pathways in thalassemic erythrocytes. Hematologic data of the patients are summarized in Table  1 (Figs 1A and 2A) . The most relevant data were (1) substantial stimulation of K-Cl cotransport and Na-Li countertransport; (2) a twofold increase of Na-K pump (with the exception of the a-trait condition); and (3) a relevant reduction of the Na-K-Cl cotransport activity ( Figs 1A-2A) . The Na-H exchange was not increased in either a-or ,&thalassemia RBCs (Figs 1A and 2A) .
The different effects on four transport systems (increased Na-K pump, K-Cl cotransport, Li countertransport, and decreased Na-K-Cl cotransport) and the lack of an increase in Na-H exchange, that is known to be elevated in young cells,2"27 indicate that cell age is not the only determinant for the increased rate of transport observed in thalassemic Exposure of erythrocytes to PHZ-and MHz-induced changes in cation transport qualitatively similar to those of p and a thalassemia. The only noteworthy difference concerned the Na-K pump, which was strongly inhibited after exposure to both oxidant drugs (Figs IB and 2B) .
Changes in the transport activities were progressively more evident with increasing concentrations of the oxidants. For PHZ-treated erythrocytes, concentrations of 5 mmol/L yielded changes of Na-Li countertransport, Na-K-Cl and KCl cotransport activities similar to those of &thalassemic cells ( Fig IB) ; at this concentration, Na-H exchange was twofold stimulated, whereas it was unaffected by lower concentrations of PHZ (Fig IB) . A progressive inhibition of the Na-K pump was observed with increasing concentrations of PHZ (Fig 1B) . For a-thalassemia-like erythrocytes, exposure to 5.7 mmolL MHZ reproduced changes in Na-Li countertransport, Na-K-C1 and K-Cl cotransport activities, similar to those of a-thalassemic cells; at these and higher concentrations, Na-H exchange was several-fold stimulated, whereas it was unaffected by lower concentrations of MHZ (Fig 2B) . Similarly to PHZ, Na-K pump was progressively inhibited by increasing concentrations of MHZ (Fig 2B) .
Properties of K-Cl cotransport in thalassemic erythrocytes. In consideration of the markedly increased K loss through K-Cl cotransport observed in 0-thalassemia and Pthalassemia-like RBCs (Fig l) , additional experiments were designed to elucidate the bases for the activation of the system in P thalassemia. Because K-Cl cotransport is represented mostly in young erythrocytes and reticulocyte^,'^ the observed increased activity could be a consequence of the presence of younger cells. However, if this is the case, the increased activity should still be limited to the lightest density fractions, as in normal human RBCs.I9 K-Cl cotransport was measured in density-fractionated cells (top fraction, least-dense cells; bottom fraction, densest cells). Table 2 shows that a sizable K-Cl cotransport was present in the dense fraction of thalassemic cells, whereas it was absent in the dense fraction of normal cells. Thus, inactivation of KCl cotransport in cells of high density is absent in thalassemic erythrocytes. Because only three subjects with severe P thalassemia were studied, it was not possible to determine whether splenectomy affects the activity of K-Cl cotransport in the different density fractions.
The susceptibility to inhibition by DIOA and OKA are well-recognized characteristic of K-Cl cotransport."." The short-term effects of DIOA on K-Cl cotransport (measured as chloride-dependent or volume-stimulated K efflux) in aand P-thalassemia erythrocytes are shown in Fig 3, A and B. About 50% of K-Cl cotransport was DIOA-sensitive in severe P thalassemia, Hb H disease and P-thalassemia trait, whereas in a trait, the inhibition by DIOA was only 28% (Fig 3, A and B) . Similar results were obtained on both p-and a-thalassemia-like erythrocytes (PHZ = 5 mmolL, MHZ = 5.7 mmol/L) in presence of DIOA (Fig 3) and with the protein phosphatase inhibitor OKA (10 ymol/L).
To evaluate the role of sulphycryl (SH)-groups oxidation on K-Cl cotransport in thalassemia, K efflux was measured in thalassemia and thalassemia-like RBCs pretreated with the reducing agent DTT (10 mmol/L). DTT strongly reduced and almost normalized K+ efflux in both P-and a-thalassemia conditions (Fig 4, A and B) , as well as in thalassemialike erythrocytes (Fig 4, A and B) .
DISCUSSION
The "membrane lesion" occurring in thalassemias is complex and not completely understood. Among the different changes observed, an altered cation membrane permeability has been reported, but the underlying mechanism has not been elucidated. As previously shown by others;,'' we found that erythrocyte K+ content was significantly reduced in P-thalassemia erythrocytes ( Table 1 ). The transport of monovalent cations was also altered in a-and P-thalassemia RBCs. We observed (1) a very strong (fourfold to ninefold) stimulation of K-Cl cotransport and Na-Li countertransport; (2) a twofold increase of Na-K pump (with the exception of the a-trait condition); (3) a relevant reduction of the Na-KCl cotransport activity and no changes in Na-H exchange activity (Figs lA-2A) . It is worth noting that K-Cl cotransport was stimulated not only in P thalassemia," but also in a thalassemia (although to a smaller extent). Whereas these findings help to explain the relative dehydration of P-thalassemia erythrocytes, they cannot account for the relative overhydration of Hb H disease. The Ca-activated K channel (Gardos pathway") was not part of these studies. It remains to be determined if the number of channel and their regulation by internal Ca is altered in thalassemic cells. The relevant alterations of membrane transport observed in thalassemia RBCs could be reproduced in normal RBCs treated with PHZ or MHZ (Figs 1 and 2) . MHZ and PHZ produced well-defined changes on both membrane proteins (confirmed by SDS-PAGE analysis*) and membrane cation transport, which strongly mimicked the abnormalities in NaLi countertransport, Na-K-Cl and K-Cl cotransport activities observed in a and 0 thalassemia. The only exception was represented by the activity of the Na-K pump, which was inhibited in oxidized erythrocytes (Fig 2) . It is worth noting that in rabbit erythrocytes, oxidation decreases the Na-K pump activity, whereas cell age increases it." The twofold stimulation of Na-K pump in thalassemia appears to be a consequence of two opposing processes: stimulation caused by the presence of younger cells and inhibition caused by concomitant oxidative membrane damage. In a previous report, 3H-ouabain binding studies on a-and P-thalassemia erythrocytes showed a 2.6-to 10-fold increase above norBecause we have not measured the number of pumps in our patients, the relative effect of oxidative damage can not be determined. A discrepancy between increased pump sites and increased flux would suggest oxidative damage effect. The similarity between changes in membrane transport observed in thalassemia and thalassemia-like RBCs indicates that membrane damage rather than cell age is the main determinant of the changes we observed in thalassemia erythrocytes.
We have shown here that P-thalassemia erythrocytes have increased K-Cl cotransportzo (Fig 1) . Another distinguishing feature of @-thalassemia erythrocytes is that increased KCl cotransport was observed in the top and bottom density fractions of thalassemia RBCs (Table 2) . K-Cl cotransport is usually observed in the least-dense, reticulocyte-rich fraction of normal RBCs, and is absent in denser fractions." This finding is similar to previous reports in SS13 and CCI5 cells and indicates that cells with increased K-Cl cotransport are present throughout the density span of thalassemia RBCs. Thus, K-Cl cotransport is a major pathway for K loss and dehydration not only in SS and CC cells, but also in pthalassemia erythrocytes.
The role of oxidation in K-Cl cotransport activation is shown by the effects of DTT (Fig 4, A and B) . Treatment with DTT reduced K-Cl cotransport in thalassemia erythrocytes to values close to control. Thus, oxidation may represent "a third factor" capable of modulating activation of K-Cl cotransport in addition to cell age and presence of p6-p7 positively charged mutations on Hb." The effect of oxidation on K-Cl cotransport has been shown in experimental models using normal cells," is potentiated by exposure to NEMZ9 and can also be shown in rabbit erythrocytes."
Membrane oxidation plays a relevant role in the alterations of membrane cation transport observed in thalassemic RBCs. It is also a major factor in the activation of K-Cl cotransport in thalassemic RBCs, which is an important determinant of the relative dehydration observed in P-thalassemia erythrocytes.
